Professor Anthony N Warrens

Publications


Journals

  • Mazaris EM; Crane JS; Warrens AN; Smith G; Tekkis P; Papalois VE. (Feb 2012). Live donor kidney transplantation: attitudes of patients and health care professionals concerning the pre-surgical pathway and post-surgical follow-up. Int Urol Nephrol. 44:157-165. DOI.
  • Mazaris EM; Crane JS; Warrens AN; Smith G; Tekkis P; Papalois VE. (May 2011). Attitudes toward live donor kidney transplantation and its commercialization. Clin Transplant. 25:E312-E319. DOI.
  • Willicombe M; Brookes P; Santos-Nunez E; Galliford J; Ballow A; Mclean A; Roufosse C; Cook HT; et alDorling A; Warrens AN; Cairns T; Taube D. (Mar 2011). Outcome of patients with preformed donor-specific antibodies following alemtuzumab induction and tacrolimus monotherapy. Am J Transplant. 11:470-477. DOI.
  • Miqueu P; Degauque N; Guillet M; Giral M; Ruiz C; Pallier A; Braudeau C; Roussey-Kesler G; et alAshton-Chess J; Doré JC; Thervet E; Legendre C; Hernandez-Fuentes MP; Warrens AN; Goldman M; Volk HD; Janssen U; Wood KJ; Lechler RI; Bertrand D; Sébille V; Soulillou JP; Brouard S. (Nov 2010). Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol. 40:3280-3290. DOI.
  • Miqueu P; Degauque N; Guillet M; Giral M; Ruiz C; Pallier A; Braudeau C; Roussey-Kesler G; et alAshton-Chess J; Doré JC; Thervet E; Legendre C; Hernandez-Fuentes MP; Warrens AN; Goldman M; Volk HD; Janssen U; Wood KJ; Lechler RI; Bertrand D; Sébille V; Soulillou JP; Brouard S. (6 Sep 2010). Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol. DOI.
  • Willicombe M; Santos-Nunez E; Brookes P; Galliford J; Stubbs N; Mclean A; Roufosse C; Cook T; et alDorling A; Warrens A; Cairns T; Taube D. (1 Oct 2010). Preformed donor specific antibodies are associated with high incidence of antibody mediated rejection despite Alemtuzumab induction. INTERNATIONAL JOURNAL OF IMMUNOGENETICS. 37:419-419.
  • McLean A; Chan K-K; Galliford J; Goodall D; Charif R; Dorling A; Warrens A; Cairns T; et alPapalois V; Hakim N; Taube D. (1 Aug 2009). RANDOMISED CONTROLLED TRIAL OF ALEMTUZUMAB-TACROLIMUS MONOTHERAPY WITH DACLIZUMAB-TACROLIMUS-MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANTATION. TRANSPLANT INTERNATIONAL. 22:91-91. Author weblink.
  • Ambrose LR; Morel AS; Warrens AN. (1 Oct 2009). Neutrophils express CD52 and exhibit complement-mediated lysis in the presence of alemtuzumab. Blood. 114:3052-3055. DOI.
  • Mazaris EM; Warrens AN; Papalois VE. (1 Mar 2009). Ethical Issues in Live Donor Kidney Transplant: Views of Medical and Nursing Staff. EXPERIMENTAL AND CLINICAL TRANSPLANTATION. 7:1-7. Author weblink.
  • Ballow AA; Sergeant R; Hernandez-Fuentes MP; Warrens AN. (1 Dec 2008). Post-transplant detection of anti-HLA antibody IgG subclasses. INTERNATIONAL JOURNAL OF IMMUNOGENETICS. 35:496-496. Author weblink.
  • Diamond H; Warrens A. (7 Nov 2008). Jack Elius Miller Obituary. BRITISH MEDICAL JOURNAL. 337. Author weblink DOI.
  • Galliford J; Charif R; Chan KK; Loucaidou M; Cairns T; Cook HT; Dorling A; Hakim N; et alMcLean A; Papalois V; Malde R; Regan F; Redman M; Warrens AN; Taube D. (15 Oct 2008). ABO Incompatible Living Renal Transplantation With a Steroid Sparing Protocol. TRANSPLANTATION. 86:901-906. Author weblink DOI.
  • Weng L; Addey C; Warrens AN; Dyson J; Chai JG; Dazzi F. (15 Nov 2008). Dissection of effector pathways in the host-versus-graft response to bone marrow transplantation. Transplantation. 86:1311-1314. DOI.
  • Herbert PE; Morgan MF; Berton I; Lechler RI; Dorling A; Williams G; Warrens AN. (1 Jul 2008). A pig allograft model of antibody-mediated rejection. TRANSPLANT IMMUNOLOGY. 19:167-172. Author weblink DOI.
  • Srikantha M; Sergeant R; Khan T; Lechler RI; Davey N; Hernandez-Fuentes MP; Warrens AN. (Oct 2008). Retrospective tissue typing of the kidney donor from recipient urine. Kidney Int. 74:952-955. DOI.
  • White LH; Casian A; Hilton R; MacPhee IAM; Marsh J; Sweny P; Trevitt R; Frankel AH; et alWarrens AN. (15 Apr 2008). BK virus nephropathy in renal transplant patients in London. TRANSPLANTATION. 85:1008-1015. Author weblink DOI.
  • Warrens AN; Baboolal K; Buist L; Dudley C; Koffman G; Lipkin G; Parrott N; Powis SH; et alSweny P; Raftery M. (1 Feb 2008). Interpreting regulatory authority guidance on immunosuppressive therapy for renal transplantation: a response to the UK's National Institute for Clinical Excellence (NICE). CLINICAL NEPHROLOGY. 69:67-76. Author weblink.
  • Steggar C; Brookes P; Davey N; Warrens A. (1 Aug 2007). The effect of pre-transplant autoantibodies on renal transplantation outcome. INTERNATIONAL JOURNAL OF IMMUNOGENETICS. 34:308-308. Author weblink.
  • Herbert, P E; Warrens, A N. (2004). Solid organ transplantation - the dynamic equilibrium of rejection and immunosuppression. International Journal of Surgery. 2:12-13.
  • Morgan MF; Warrens AN. (2001). Determining compatibility of adhesion molecules. Graft. 4:40-43.
  • Warrens AN; Lechler RI. (2001). Cardiac xenotransplantation. Cardioguardian. 3-7.
  • Herbert PE; Warrens AN. (2004). Solid Organ Transplantation - the dynamic equilibrium of rejection and immunosuppression. Journal of Surgery. 2:12-13.
  • Dupont PJ; Warrens AN. (2001). Cholesterol emboli syndrome. Journal of the Irish Colleges of Physicians and Surgeons. 30:219-222.
  • MOSCICKI R; WARRENS A; KURNICK JT; COLVIN RB. (1 Jan 1982). HUMAN T-CELL SUBSET CHANGES IDENTIFIED BY MONOCLONAL-ANTIBODIES AFTER PHA STIMULATION. FEDERATION PROCEEDINGS. 41:328-328. Author weblink.
  • KURNICK JT; AHERN AT; PINTO CE; WARRENS A; KARR RW; FULLER TC. (1 Jan 1983). THE USE OF INVITRO PROPAGATED SOLUBLE ANTIGEN-SPECIFIC HUMAN T-CELL BLASTS AS HLA-D/DR REAGENTS. TRANSPLANTATION PROCEEDINGS. 15:113-117. Author weblink.
  • Sergeant R; Khan T; Hernandez M; Davey N; Warrens A. (1 Aug 2006). Typing of absent renal donors. INTERNATIONAL JOURNAL OF IMMUNOGENETICS. 33:326-326. Author weblink.
  • Dorling A; Riesbeck K; Warrens A; Lechler R. (22 Mar 1997). Clinical xenotransplantation of solid organs. Lancet. 349:867-871. DOI.
  • Kumar R; Herbert PE; Warrens AN. (2005). An introduction to death receptors in apoptosis. Int J Surg. 3:268-277. DOI.
  • Villegas-Mendez A; Montes R; Ambrose LR; Warrens AN; Laffan M; Lane DA. (May 2007). Proteolysis of the endothelial cell protein C receptor by neutrophil proteinase 3. J Thromb Haemost. 5:980-988. DOI.
  • Dupont PJ; Warrens AN. (1 Jan 2007). Fas ligand exerts its pro-inflammatory effects via neutrophil recruitment but not activation. IMMUNOLOGY. 120:133-139. Author weblink DOI.
  • Dooldeniya MD; Dupont PJ; He X; Johnson RJ; Joshi T; Basra R; Johnston A; Warrens AN. (Apr 2006). Renal transplantation in Indo-Asian patients in the UK. Am J Transplant. 6:761-769. DOI.
  • Tuthill MH; Stratton J; Warrens AN. (Jan 2006). Calcific uremic arteriolopathy presenting with small and large bowel involvement. J Nephrol. 19:115-118.
  • Isaacs JD; Rakshi J; Baker R; Brooks DJ; Warrens AN. (Dec 2005). Chorea associated with thyroxine replacement therapy. Mov Disord. 20:1656-1657. DOI.
  • Dooldeniya MD; Dupont PJ; Ambrose LR; Lechler RI; Simpson E; Dyson PJ; Warrens AN. (1 Dec 2005). Fas ligand is a mediator of relative immune privilege in non-specialised peripheral tissue in inflammation. IMMUNOLOGY. 116:44-44. Author weblink.
  • Ambrose LR; Smith LM; Little MA; Dupont PJ; Herbert PE; Williams G; Lombardi G; Warrens AN. (1 Dec 2005). PMNs as APCs in transplantation: bridging innate and adaptive immunity. IMMUNOLOGY. 116:48-48. Author weblink.
  • Alkhawari FS; Stimson GV; Warrens AN. (Jun 2005). Attitudes toward transplantation in U.K. Muslim Indo-Asians in west London. Am J Transplant. 5:1326-1331. DOI.
  • Mirenda V; Golshayan D; Read J; Berton I; Warrens AN; Dorling A; Lechler RI. (Apr 2005). Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses. Diabetes. 54:1048-1055.
  • Herbert PE; Lynch M; Morgan F; Berton I; Eckersley R; Williams G; Blomley M; Warrens AN. (27 Mar 2005). Cyclosporine A does not alter ultrasonic indices of renal blood flow: a potential tool for differentiating toxicity from acute rejection?. Transplantation. 79:731-734.
  • Cardozo LA; Rouw DB; Ambrose LR; Midulla M; Florey O; Haskard DO; Warrens AN. (27 Dec 2004). The neutrophil: the unnoticed threat in xenotransplantation?. Transplantation. 78:1721-1728.
  • Griffiths EJ; Nelson RE; Dupont PJ; Warrens AN. (15 Jun 2004). Skewing of pretransplant anti-HLA class I antibodies of immunoglobulin G isotype solely toward immunoglobulin G1 subclass is associated with poorer renal allograft survival. Transplantation. 77:1771-1773.
  • Chen D; Morgan F; Berton I; Herbert PE; Lechler RI; Dorling A; Williams G; Warrens AN. (15 May 2004). Developing a porcine transplantation model: efficient gene transfer into porcine vascular cells. Transplantation. 77:1443-1451.
  • Haji NI; Nelson RE; Jones MN; Johnson RJ; De Silva M; Malde R; Warrens AN. (27 Feb 2004). Will transplantation of kidneys from donors with blood group A2 into recipients with blood group B help British Indo-Asian patients with renal failure?. Transplantation. 77:630-633.
  • Hernandez-Fuentes MP; Warrens AN; Lechler RI. (Dec 2003). Immunologic monitoring. Immunol Rev. 196:247-264.
  • James MJ; Belaramani L; Prodromidou K; Datta A; Nourshargh S; Lombardi G; Dyson J; Scott D; et alSimpson E; Cardozo L; Warrens A; Szydlo RM; Lechler RI; Marelli-Berg FM. (15 Sep 2003). Anergic T cells exert antigen-independent inhibition of cell-cell interactions via chemokine metabolism. Blood. 102:2173-2179. DOI.
  • Alenzi FQ; Warrens AN. (15 Sep 2003). Cellular and molecular themes in apoptosis. Wien Klin Wochenschr. 115:563-574.
  • Dupont PJ; Dooldeniya M; Cook T; Warrens AN. (Sep 2003). Role of duplex Doppler sonography in diagnosis of acute allograft dysfunction-time to stop measuring the resistive index?. Transpl Int. 16:648-652. DOI.
  • Dupont P; Warrens AN. (Jun 2003). The evolving role of sirolimus in renal transplantation. QJM. 96:401-409.
  • Dooldeniya MD; Warrens AN. (Mar 2003). Xenotransplantation: where are we today?. J R Soc Med. 96:111-117.
  • Warrens AN. (2003). On the horizon: tailor-made immunosuppression in renal transplantation. Nephron Clin Pract. 94:c5-10. DOI.
  • Alenzi FQ; Marley SB; Lewis JL; Chandrashekran A; Warrens AN; Goldman JM; Gordon MY. (Dec 2002). A role for the Fas/Fas ligand apoptotic pathway in regulating myeloid progenitor cell kinetics. Exp Hematol. 30:1428-1435.
  • Warrens AN. (Dec 2002). Biological therapy in transplantation: an update from the 19th International Congress of the Transplantation Society. Expert Opin Biol Ther. 2:993-996. DOI.
  • Warrens AN. (Nov 2002). Pharmacological control of the immune response in renal transplantation. BJU Int. 90:784-791.
  • Dupont PJ; Dooldeniya M; Herbert P; Warrens AN. (1 Sep 2002). Acute rejection occurs earlier and with greater frequency in living-donor versus cadaveric renal transplant recipients. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 13:186A-186A. Author weblink.
  • Dupont P; Hunt I; Goldberg L; Warrens A. (Jul 2002). Colchicine myoneuropathy in a renal transplant patient. Transpl Int. 15:374-376. DOI.
  • Theodore PR; Simon AR; Warrens AN; Sackstein R; Sykes M. (Jul 2002). Porcine mononuclear cells adhere to human fibronectin independently of very late antigen-5: implications for donor-specific tolerance induction in xenotransplantation. Xenotransplantation. 9:277-289.
  • Harvey CJ; Lynch M; Blomley MJ; Cosgrove DO; Eckersley RJ; Warrens AN. (1 Nov 2001). Can renal arteriovenous transit time measured using bolus injections of the ultrasound microbubble levovist (SHU 508A) characterize the vasculopathy in acute renal allograft rejection?. RADIOLOGY. 221:418-418. Author weblink.
  • Game DS; Warrens AN; Lechler RI. (30 Oct 2001). Rejection mechanisms in transplantation. Wien Klin Wochenschr. 113:832-838.
  • Dupont P; Jackson J; Warrens A; Lightstone L. (Apr 2001). Life-threatening thrombosis 18 years after first presentation of primary antiphospholipid antibody syndrome. Nephrol Dial Transplant. 16:843-845.
  • Dupont PJ; Lightstone L; Clutterbuck EJ; Gaskin G; Pusey CD; Cook T; Warrens AN. (28 Oct 2000). Lesson of the week: cholesterol emboli syndrome. BMJ. 321:1065-1067.
  • Warrens AN; Simon AR; Theodore PR; Sachs DH; Sykes M. (15 Feb 2000). Cross-species compatibility of intercellular adhesion molecule-1 (CD54) with its ligands. Transplantation. 69:394-399.
  • Warrens AN. (Jan 2000). The evolving role of mycophenolate mofetil in renal transplantation. QJM. 93:15-20.
  • Sofat N; Bell S; Turner J; Warrens AN. (Jul 1999). A case of acute renal failure and compartment syndrome after an alcoholic binge. J Accid Emerg Med. 16:296-298.
  • Simon AR; Warrens AN; Sykes M. (Jul 1999). Efficacy of adhesive interactions in pig-to-human xenotransplantation. Immunol Today. 20:323-330.
  • Warrens AN; Simon AR; Theodore PR; Sykes M. (May 1999). Human-porcine receptor-ligand compatibility within the immune system: relevance for xenotransplantation. Xenotransplantation. 6:75-78.
  • Warrens AN; Waters JB; Salama AD; Lechler RI. (Apr 1999). Improving the therapeutic monitoring of cyclosporin A. Clin Transplant. 13:193-200.
  • Simon AR; Warrens AN; Yazzie NP; Seebach JD; Sachs DH; Sykes M. (15 Aug 1998). Cross-species interaction of porcine and human integrins with their respective ligands: implications for xenogeneic tolerance induction. Transplantation. 66:385-394.
  • Theodore PR; Simon AR; Warrens AN; Sackstein R; Sykes M. (1 Aug 1998). Divergence of integrin function in hematopoiesis in the pig to human xenogeneic combination: Implications for bone marrow induced donor-specific tolerance. EXPERIMENTAL HEMATOLOGY. 26:778-778. Author weblink.
  • Warrens AN; Simon AR; Theodore PR; Sachs DH; Sykes M. (27 Jul 1998). Function of porcine adhesion molecules in a human marrow microenvironment. Transplantation. 66:252-259.
  • Warrens AN; Jones MD; Lechler RI. (20 Feb 1997). Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene. 186:29-35.
  • Warrens AN. (Jan 1997). Studies on the interaction of T-cells with major histocompatibility complex class II antigens. Clin Sci (Lond). 92:25-36.
  • Warrens AN; Dorling A; Lechler RI. (Dec 1996). The prospects for xenotransplantation. QJM. 89:885-891.
  • Warrens AN; Salama A; Waters JB; Lechler RI. (Aug 1996). Comparison of Neoral and Sandimmune preparations in renal transplant patients--improved pharmacokinetics with neoral. Transplant Proc. 28:2169-2170.
  • Hargreaves RE; Brehm RD; Tranter H; Warrens AN; Lombardi G; Lechler RI. (Dec 1995). Definition of sites on HLA-DR1 involved in the T cell response to staphylococcal enterotoxins E and C2. Eur J Immunol. 25:3437-3444. DOI.
  • Lombardi G; Warrens AN; Lechler RI. (Feb 1995). Anergic T cells act as suppressor cells in vitro. Transplant Proc. 27:235-236.
  • Mason PD; Warrens AN; Lechler RI. (Feb 1995). Could analysis of helper T-cell precursor frequencies be used as a predictive parameter in renal transplantation?. Transplant Proc. 27:230-231.
  • Warrens AN; Lechler RI. (Jun 1994). Customised immunosuppression. Bone Marrow Transplant. 13:671-673.
  • Warrens AN; Zhang JY; Sidhu S; Watt DJ; Lombardi G; Sewry CA; Lechler RI. (Jun 1994). Myoblasts fail to stimulate T cells but induce tolerance. Int Immunol. 6:847-853.
  • Warrens AN; Lombardi G; Lechler RI. (Jun 1994). Presentation and recognition of major and minor histocompatibility antigens. Transpl Immunol. 2:103-107.
  • Warrens AN; Heaton T; Sidhu S; Lombardi G; Lechler RI. (28 Feb 1994). Transfected murine cells expressing HLA class II can be used to generate alloreactive human T cell clones. J Immunol Methods. 169:25-33.
  • Lam HC; Takahashi K; Ghatei MA; Warrens AN; Rees AJ; Bloom SR. (1991). Immunoreactive endothelin in human plasma, urine, milk, and saliva. J Cardiovasc Pharmacol. 17 Suppl 7:S390-S393.
  • Warrens AN; Cassidy MJ; Takahashi K; Ghatei MA; Bloom SR. (1990). Endothelin in renal failure. Nephrol Dial Transplant. 5:418-422.
  • Warrens AN; Ron MA; Dawling S. (Jan 1990). Positive diagnosis of self-medication with homatropine eye drops. Br J Psychiatry. 156:124-125.
  • Warrens AN; Heaton JM. (Sep 1987). Thoracic outlet compression syndrome: the lack of reliability of its clinical assessment. Ann R Coll Surg Engl. 69:203-204.
  • WARRENS AN; BARNES PJ; COLE PJ; MITCHELL DN. (1 Sep 1986). PULSED INTRAVENOUS METHYLPREDNISOLONE THERAPY FOR REFRACTORY SARCOIDOSIS. THORAX. 41:714-715. Author weblink.
  • MOLITOR PJA; WARRENS AN. (1 Jan 1985). ACUTE ORCHITIS ASSOCIATED WITH HEPATITIS-B INFECTION. BRITISH MEDICAL JOURNAL. 291:940-940. Author weblink.

Books

  • Warrens AN. Lechler RI (ed); Warrens AN (ed). HLA in Health and Disease. Academic Press, London (2000).
  • Warrens, A N; Powis, S H; Persey, M; Zumla, A. A Guide to the MRCP Part 2 Written Paper. First Edition. Chapman and Hall, London (1994).
  • Warrens, A N; Persey, M; Fertleman, M; Powis, S H; Zumla, A. A Guide to the MRCP Part 2 Written Paper. Second Edition. Hodder Arnold, London (2005).
  • Hope, R A; Longmore, J M; Moss, P A H; Warrens, A N. Oxford Handbook of Clinical Medicine. Second Edition. Oxford University Press, Oxford (1989).

Chapters in books

  • Warrens, A N. Renal failure. In Case presentations for the MRCS and AFRCS. 2:4-9. Hornick (ed); Lumley P (ed); Grace J (ed); P (ed). Butterworth Heinemann, London (1997).
  • Warrens, A N. Renal failure. In Case presentations for the MRCS and AFRCS. 1:6-10. Hornick (ed); Lumley P (ed); Grace J (ed); P (ed). Butterworth Heinemann, London (1997).
  • Dupont, P J; Herbert, P E; Warrens, A N. Mechanisms of allorecognition. In Actualites Nephrologiques Jean Hamburger: Hopital Necker. Lesavre (ed); Drueke P (ed); Legendre T (ed); Niaudet C (ed); P (ed). Flammarion Medicine-Sciences, Paris (2003).
  • Warrens, A N. Immunosuppressive drugs in renal transplantation - 2006. In Horizons in Medicine - 17. 71-77. Haskard DO (ed). Royal College of Physicians of London (2006).
  • Simon, A R; Warrens, A N. Adhesion molecules in xenotransplantation. In Adhesion molecules in organ transplantation. Steinhoff G (ed). Springer Verlag (1997).
  • Dupont PJ; Herbert PE; Warrens AN. Mechanisms of allorecognition. In Actualites Nephrologiques Jean Hamburger. 285-298. Lesavre P (ed); Drueke T (ed); Legendre C (ed); Niaudet P (ed). Flammarion (2003).
  • Warrens AN. The Renal Transplant Recipient. In Acute Renal Failure in Practice. 453-464. Glynne P (ed); Allen A (ed); Pusey C (ed). Imperial College Press (2002).

Conferences

  • Lawrence C; Willicombe M; Brookes P; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; et alWarrens AN. Preformed Anti-HLA -A, -B and -DR but Not -DQ Complement-Activating Low-Level Donor- Specific Antibodies Predict Early Antibody- Mediated Rejection in Renal Allografts. American Transplant Congress, 2011. 11:471-472. WILEY-BLACKWELL (1 Apr 2011). Author weblink.
  • Jain N; Hoyle T; Warrens A. Organ Donation in Black and Minority Ethnic Communities in the UK: Using Peer Educators To Access Hitherto "Hard-to-Reach" Populations. 10th American Transplant Congress, 1 May 2010 - 5 May 2010. 10:289-289. WILEY-BLACKWELL PUBLISHING, INC (1 Apr 2010).
  • Willicombe M; Brookes P; Galliford J; McLean A; Warrens A; Cairns T; Taube D. De Novo Donor Specific Antibodies Are Associated with Antibody Mediated Rejection in Patients Receiving Alemtuzumab Induction. 10th American Transplant Congress, 1 May 2010 - 5 May 2010. 10:234-235. WILEY-BLACKWELL (1 Apr 2010).
  • Willicombe M; Galliford J; Corbett R; Filiopoulis V; McLean A; Roufosse C; Warrens A; Cairns T; et alTaube D. Donor Specific Antibody Titres Predict Antibody Mediated Rejection and Response to Treatment. 10th American Transplant Congress, 1 May 2010 - 5 May 2010. 10:234-234. WILEY-BLACKWELL (1 Apr 2010).
  • Willicombe M; Brookes P; Galliford J; McLean A; Warrens A; Cairns T; Taube D. Preformed Donor Specific Antibodies Are Associated with High Incidence of Antibody Mediated Rejection Despite Alemtuzumab Induction. 10th American Transplant Congress, 1 May 2010 - 5 May 2010. 10:164-164. WILEY-BLACKWELL PUBLISHING, INC (1 Apr 2010).
  • Galliford J; Chan K; Lawrence C; Willicombe M; Charif R; Roufosse C; Cook HT; Warrens AN; et alCairns T; Lee J; McLean A; Papalois V; Taube D. Antibody Mediated Rejection after ABO Incompatible Living Donor Renal Transplantation Is Mainly Associated with HLA Donor Specific Antibodies. 10th American Transplant Congress, 1 May 2010 - 5 May 2010. 10:164-164. WILEY-BLACKWELL PUBLISHING, INC (1 Apr 2010).
  • Hernandez-Fuentes M; Perucha E; Sagoo P; Sawitzki B; Tomiuk S; Stephens DA; Miqueu P; Chapman S; et alCraciun L; Brouard S; Giral M; Seyfert-Margolis V; Newell K; Turka L; Goldman M; Wood K; Warrens A; Volk HD; Soulillou JP; Janssen U; Lechler RI. Validated Biomarkers of Immune Tolerance in Renal Transplants. 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, 30 May 2009 - 3 Jun 2009. 9:624-624. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Galliford J; Chan K; Willicombe M; Roufosse C; Hakim N; Papalois V; Warrens A; McLean A; et alCook T; Taube D. Renal Allograft Rejection after Alemtuzumab Induction and Tacrolimus Monotherapy. 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, 30 May 2009 - 3 Jun 2009. 9:620-621. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • McDermott J; Rice B; Harcourt N; Ayton-Tyler J; Reece P; Dulku H; Chan EK; Papalois V; et alTaube D; Warrens AN. Ethnicity May Not Be a Factor in Determining Availability of Live Donors. 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, 30 May 2009 - 3 Jun 2009. 9:604-604. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Willicombe M; Chan K; Galliford J; Brookes P; Ballow A; Cairns T; Dorling A; Warrens A; et alMcLean A; Taube D. Significance of Preformed Anti-HLA Antibodies in Patients Receiving Steroid Sparing Immunosuppression Protocols. 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, 30 May 2009 - 3 Jun 2009. 9:509-509. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Chan K; Galliford J; Goodall D; Charif R; Dorling A; Warrens A; Hakim N; Papalois V; et alTaube D; McLean A. Randomised Controlled Trial of Alemtuzumab and Tacrolimus Monotherapy with Daclizumab, Tacrolimus and Mycophenolate Mofetil in Renal Transplantation. 9th Joint Meeting of the American-Society-of-Transplant-Surgeon/American-Society-of-Transplantation, 30 May 2009 - 3 Jun 2009. 9:282-282. WILEY-BLACKWELL PUBLISHING, INC (1 Jan 2009). Author weblink.
  • Galliford J; Shiu K; Chan K; England M; Cook T; McLean A; Warrens A; Taube D; et alDorling A. Treatment of late antibody mediated rejection in renal transplant recipients. 8th American Transplant Congress. 8:442-443. (May 2008).
  • Chan K; Galliford J; Charif R; Betmouni R; Dorling A; Hakim N; McLean A; Papalois V; et alWarrens A; Taube D. Campath and tacrolimus monotherapy without steroids or mycophenolate mofetil: 3 year results. 8th American Transplant Congress. 8:440-440. (May 2008).
  • Galliford JW; Chan K; McLean AG; Cook HT; Charif R; Dorling A; Warrens AN; Taube D. Renal allograft rejection after Campath induction and medium dose tacrolimus monotherapy without steroids. 8th American Transplant Congress, 31 May 2008 - 4 Jun 2008. 8:580-580. BLACKWELL PUBLISHING (1 May 2008). Author weblink.
  • Charif R; Chan K; Canelo R; Hakim N; McLean A; Palmer A; Papalois V; Warrens A; et alTaube D. Campath induction and Tacrolimus monotherapy in simultaneous kidney and pancreas transplantation. 8th American Transplant Congress, 31 May 2008 - 4 Jun 2008. 8:553-553. BLACKWELL PUBLISHING (1 May 2008). Author weblink.
  • Fuentes MH; Sawitzki B; Perucha E; Sagoo P; Miqueu P; Chapman S; Stephens D; Craciun L; et alTomiuk S; Brouard S; Giral M; Janssen U; Goldman M; Wood K; Warrens A; Volk H-D; Soulillou JP; Lechler R. Identification of immune tolerance in renal transplants. 8th American Transplant Congress, 31 May 2008 - 4 Jun 2008. 8:292-292. BLACKWELL PUBLISHING (1 May 2008). Author weblink.
  • Chan K; Taube D; Galliford J; Charif R; Dorling A; Goodall D; Hakim N; Papalois V; et alWarrens A; McLean A. Randomised controlled trial of campath and tacrolimus-monotherapy with daclizumab, tacrolimus and mycophenolate mofetil in renal transplantation; Interim results. 8th American Transplant Congress, 31 May 2008 - 4 Jun 2008. 8:216-216. BLACKWELL PUBLISHING (1 May 2008). Author weblink.
  • Miqueu P; Guillet M; Giral M; Ruiz C; Braudeau C; Hernandez-Fuentes M; Le Moine A; Sawitzki B; et alWarrens A; Goldman M; Volk H-D; Wood K; Lechler R; Sebille V; Bertrand D; Brouard S; Soulilllou JP. T cell repertoire analysis of stable kidney graft recipients for detection of low and high risk of chronic rejection. 8th Annual Meeting of the Federation-of-Clinical-Immunology-Societies, 5 Jun 2008 - 9 Jun 2008. 127:S74-S75. ACADEMIC PRESS INC ELSEVIER SCIENCE (1 Jan 2008). Author weblink DOI.
  • Onions L; Brookes P; Mclean A; Taube D; Warrens A; Dorling A; Salama A. Generation of regulatory T cells in renal transplant recipients following induction therapy with Campath-1H and Daclizumab. 33rd Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics. 68:S39-S39. (Jan 2007).
  • Chen D; Berton I; Herbert PE; Morgan MF; Williams G; Lechler RI; Dorling A; Warrens AN. Successful in vivo transfection of non-dividing endothelium by DAPI-supplemented liposome-packaged DNA. 7th Congress of the International-Xenotransplantation-Association. 10:512-512. (Sep 2003).
  • Ambrose L; Cardozo L; Rouw D; Midulla M; Warrens AN. The role of polymorphonuclear granulocytes in the direct recognition of xenogeneic endothelium. 7th Congress of the International-Xenotransplantation-Association. 10:502-502. (Sep 2003).
  • Dooldeniya MD; Morgan F; Dyson PJ; Warrens AN. The role of graft expressed Fas-ligand in rejection. 7th Congress of the International-Xenotransplantation-Association. 10:485-485. (Sep 2003).
  • Mirenda V; Read J; Berton I; Warrens A; Dorling A; Lechler RI. Porcine CTLA4-Ig as a specific reagent to prevent direct pathway xenospecific T cell sensitization. 7th Congress of the International-Xenotransplantation-Association. 10:484-484. (Sep 2003).
  • Mirenda V; Read J; Berton I; Warrens A; Lechler R. Porcine CTLA4-Ig as a species-specific reagent to prevent direct pathway xenospecific T cell sensitization. American Transplant Congress. 4:449-449. (Aug 2004).
  • Dupont PJ; Griffiths EJ; Nelson RE; Warrens AN. Pre-transplant anti-HLA class I antibodies of IgG isotype skewed solely towards the IgG, subclass are associated with poorer renal allograft survival. American Transplant Congress. 4:257-257. (Aug 2004).
  • Dooldeniya MD; Dupont PJ; Ambrose LR; Herbert PE; Tzivanikis A; Fazekasova H; Lombardi G; Warrens AN. Thymosin beta-4 sulphoxide - An anti-inflammatory peptide with novel immunosuppressant properties. American Transplant Congress. 4:195-195. (Aug 2004).
  • Kumar R; Herbert PE; Warrens AN. Mechanisms of action of TRAIL in inhibiting immune response to alogeneic tissue. Annual American Transplant Congress. 7:148-148. (May 2007).
  • Sawitzki BS; Hernandez-Fuentes M; Sagoo P; Perucha E; Lemoine A; Brouard S; Chapman S; Peters B; et alRoberts I; Janssen U; Soulillou JP; Warrens A; Wood K; Goldman M; Lechler R; Volk HD. Identification of tolerant patients based on a combinational analysis of foxp3 and aMannosidase transcription. Annual American Transplant Congress. 7:488-488. (May 2007).
  • Hernandez-Fuentes MP; Sawitzki B; Sagoo P; Craciun L; Brouard S; Perucha E; Chapman S; Bradeau C; et alPeters B; Roberts I; Sergeant R; Janssen U; Warrens A; Wood K; Soulillou JP; Goldman M; Volk HD; Lechler RI. Biomarkers of tolerance in kidney transplants. Annual American Transplant Congress. 7:337-337. (May 2007).
  • Srikantha M; Sergeant R; Hernandez-Fuentes M; Lechler RI; Warrens AN. Is it possible totissue type a kidney donor who is no longer available?. Annual American Transplant Congress. 7:268-268. (May 2007).
  • Hernandez-Fuentes MP; Sagoo P; Sawitzki B; Perucha E; Jimenez-Vera E; Craciun L; Brouard S; Chapman S; et alJansen U; Warrens AN; Goldman M; Volk HD; Soulillou JP; Wood K; Lechler RI. Tregs in peripheral blood of clinically defined groups of renal transplant recipients. Annual Congress of the British-Society-of-Immunology. 120:10-10. (Mar 2007).
  • Ambrose L; Smith L; Little M; Dupont P; Williams G; Warrens A. Neutrophils as antigen-presenting cells in transplantation: Bridging innate and adaptive immunity. 43rd ERA-EDTA Congress, 15 Jul 2006 - 18 Jul 2006. 21:549-549. OXFORD UNIV PRESS (1 Jul 2006). Author weblink.
  • Gjorgjimajkoska O; Sergeant R; Brookes P; Davey N; Warrens A. Specific donor FasR and FasL genotypes may be associated with increased acute cellular rejection in renal transplant recipients. 32nd Annual Meeting of the American-Society-for-Histocompatibility-and-Immunogenetics, 16 Oct 2006 - 20 Oct 2006. 67:S104-S104. ELSEVIER SCIENCE INC (1 Oct 2006). Author weblink DOI.
  • Ambrose LR; Smith LM; Little MAP; Dupont PJ; Warrens AN. Neutrophils as antigen-presenting cells: Bridging innate and adaptive immunity. Annual American Transplant Congress, 5 May 2007 - 9 May 2007. 7:412-412. BLACKWELL PUBLISHING (1 May 2007). Author weblink.
  • Sagoo P; Sawitzki B; Hernandez-Fuentes M; Perucha E; Craciun L; Brouard S; Chaprnan S; Bradeau C; et alPeters B; Roberts I; Janssen U; Soulillou JP; Warrens AN; Wood K; Goldman M; Volk HD; Lechler RI. Monitoring peripheral blood regulatory T cells on clinically defined groups of kidney transplant recipients. Annual American Transplant Congress, 5 May 2007 - 9 May 2007. 7:340-340. BLACKWELL PUBLISHING (1 May 2007). Author weblink.
  • Morgan MF; Berton I; Herbert PE; Williams G; Lechler RI; Dorling A; Warrens AN. The development of a pig allograft model as a surrogate for hyperacute rejection in xenotransplantation. 7th Congress of the International-Xenotransplantation-Association, 2003. 10:528-528. BLACKWELL MUNKSGAARD (1 Sep 2003). Author weblink.
  • LAM HC; TAKAHASHI K; GHATEI MA; WARRENS AN; REES AJ; BLOOM S. IMMUNOREACTIVE ENDOTHELIN IN HUMAN PLASMA, URINE, MILK, AND SALIVA. 2ND INTERNATIONAL CONF ON ENDOTHELIN, 9 Dec 1990 - 12 Dec 1990. 17:S390-S393. LIPPINCOTT-RAVEN PUBL (1 Jan 1991). Author weblink DOI.

Patents

  • Efficient gene transfer into porcine vascular cells using 4’,6’-diamidino-2-phenylindole (DAPI). Patent number: WO2005/023312. Application: GB0320627.3. Chen D; Dorling A; Lechler RI. Filed: May 2005.
  • The use of thymosin beta-4 sulphoxide as an immunosuppressant. Patent number: WO2005/027958. Application: GB04/003950. Dupont PJ; Dooldeniya MD. Filed: Mar 2005.
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook